2013 - Fellow of the American Society of Tropical Medicine and Hygiene (ASTMH)
Her primary scientific interests are in Immunology, Vaccination, Diarrhea, Virology and Microbiology. Her research in Immunology intersects with topics in Shigella, Shigella vaccine and Clinical trial. Her Vaccination course of study focuses on Bacterial vaccine and Clostridium difficile, Colitis and Immunoglobulin G.
Many of her studies on Diarrhea involve topics that are commonly interrelated, such as Incidence. Her Virology research integrates issues from Group A, Salmonella typhi and Streptococcus pyogenes. Her study in Microbiology is interdisciplinary in nature, drawing from both Genotype, Multiplex polymerase chain reaction, Virulence and Enterotoxin.
Karen L. Kotloff spends much of her time researching Diarrhea, Immunology, Pediatrics, Virology and Vaccination. Her Diarrhea research is multidisciplinary, incorporating elements of Shigella, Epidemiology and Environmental health. Her research investigates the connection with Shigella and areas like Microbiology which intersect with concerns in Salmonella typhi.
Her work deals with themes such as Health care, Case fatality rate, Incidence, Pneumonia and Severity of illness, which intersect with Pediatrics. Her studies in Virology integrate themes in fields like Group A and Genotype. Her biological study spans a wide range of topics, including Adverse effect and Bacterial vaccine, Immunization, Conjugate vaccine.
Karen L. Kotloff mostly deals with Diarrhea, Internal medicine, Environmental health, Vaccination and Pediatrics. Her Diarrhea study combines topics in areas such as Antibiotics, Epidemiology and Virology. Her Internal medicine research incorporates elements of Shigella and Shigellosis.
She has researched Environmental health in several fields, including Psychological intervention, Sanitation, Verbal autopsy, Cause of death and Incidence. The study incorporates disciplines such as Antibody titer, Adverse effect, Immunization, Immunogenicity and Dosing in addition to Vaccination. Karen L. Kotloff combines subjects such as Pregnancy and Clinical trial with her study of Pediatrics.
Karen L. Kotloff mainly focuses on Environmental health, Internal medicine, Etiology, Diarrhea and Cause of death. The concepts of her Environmental health study are interwoven with issues in Psychological intervention, Incidence, Child mortality and Cryptosporidium. Her Incidence research incorporates themes from Attributable risk and Disease, Disease burden.
Her research in Internal medicine intersects with topics in Shigella sonnei and Shigella. Her Diarrhea research is multidisciplinary, incorporating perspectives in Polymerase chain reaction, Epidemiology, Risk factor and Case-control study. Her Antigen research is multidisciplinary, relying on both Shigellosis and Vaccination.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study.
Ting Shi;David A. McAllister;Katherine L. O'Brien;Eric A. F. Simoes.
The Lancet (2017)
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016
Christopher Troeger;Brigette F Blacker;Ibrahim A Khalil;Puja C Rao.
Lancet Infectious Diseases (2018)
Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses.
John J Treanor;Karen Kotloff;Robert F Betts;Robert Belshe.
Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in U.S. Volunteers
Carol O. Tacket;Marcelo B. Sztein;Steven S. Wasserman;Genevieve Losonsky.
Infection and Immunity (2000)
Safety and Immunogenicity of Oral Inactivated Whole-Cell Helicobacter pylori Vaccine with Adjuvant among Volunteers with or without Subclinical Infection
Karen L. Kotloff;Marcelo B. Sztein;Steven S. Wasserman;Genevieve A. Losonsky.
Infection and Immunity (2001)
Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial
Milagritos D Tapia;Samba O Sow;Boubou Tamboura;Ibrahima Tégueté.
Lancet Infectious Diseases (2016)
Diarrhea in young children from low-income countries leads to large-scale alterations in intestinal microbiota composition
Mihai Pop;Alan W Walker;Joseph Paulson;Brianna Lindsay.
Genome Biology (2014)
Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.
Carol O. Tacket;Mitchell B. Cohen;Steven S. Wasserman;Genevieve Losonsky.
Infection and Immunity (1999)
Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults.
Karen L. Kotloff;Steven S. Wasserman;Genevieve A. Losonsky;William Thomas.
Infection and Immunity (2001)
Clostridium difficile Vaccine and Serum Immunoglobulin G Antibody Response to Toxin A
Samer Aboudola;Karen L. Kotloff;Lorraine Kyne;Michel Warny.
Infection and Immunity (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: